Share Print

Funding Opportunities in Cancer Research

 

research1  

For assistance with funding, contact: 
Paige Isom, Research Adminstrator,
Funding and Awards
Phone: 314-454-8980
E-mail:  isomp@wudosis.wustl.edu

 

 

FUNDING OPPORTUNITY SEARCH TOOLS 

Siteman Cancer Center — Internal

Barnes-Jewish Foundation
  

Deadline Funding Opportunity Sponsor Amount Description
April 13, 2015 Internal: Grants for new investigators Edward Mallinckrodt Jr. Foundation $60,000 per year up to 3 years Grants for New Investigators support basic biomedical research projects that are in need of initial start-up funding to move the projects forward. Applicants with R01 funding should not apply.
April 13, 2015 Internal: Pew-Stewart Scholars Program for Cancer Research Pew Charitable Trusts and the Alexander and Margaret Stewart Trust $240,000 over a 4 year period Designed to support promising early career scientists whose research will accelerate discovery and advance progress to a cure for cancer.
April 13, 2015 Internal: Cancer Research Foundation Young Investigator Award Cancer Research Foundation $75,000 These awards are designed to nurture young scientists in the pursuit of independent hypotheses, and to enable them to develop the preliminary data necessary to successfully compete for major research grants.
April 24, 2015 Worldwide Research Grant Worldwide Cancer Research (formerly AICR) Maximum budget of £250,000 The goal of this grant is to support research that might in future help reduce the incidence of cancer or improve cancer survival. Grants support basic or translational research into the causes, mechanisms, diagnosis, treatment or prevention of cancer.
May 1, 2015 Internal: SPORE in Leukemia Career Enhancement Awards/Development Research Awards WUSM Spore in Leukemia $60,000 per year for two years  CEP: The research initiatives that will be funded by the CEP are expected to have a major translational component, focusing on leukemia etiology, diagnosis, early detection, treatment, or population science.
DRP: The goal is to support innovative translational leukemia research. Proposed projects will be reviewed with the intent that they will develop sufficiently, within one-two years, to be submitted for external peer-reviewed funding. For projects with a clinical trial, they must be ready to study activation within six months of award.
May 1 and Oct. 1, 2015 Internal: Siteman Investment Program Siteman Cancer Center Varies from $200,000 to $800,000 over 2 years SCC will fund the following mechanisms: Pre-R01 for WUSTL Medical School Faculty, Pre-R01 for SLU Consortium Faculty and WUSTL Danforth Campus Faculty, Multi-PI Pre-R01 for all SCC members, Pre-SPORE/PPG Program for all SCC Members.
June 1, 2015 Elsa U. Pardee Foundation Grant  Elsa U. Pardee Foundation $100,000 for one year This Foundation supports discovery of new approaches for cancer treatment and cure. Previous WU awardees: Albert Kim (2013); David Tran (2013); Joshua Hood (2009); Mai Xu (2009); Sheila Stewart (2007); Jason Weber (2005); Steven Weintraub (2005); Rebecca Aft (2003); Tim Fleming (2001)
June 5, 2015 New: Research Projects to Enhance Applicability of Mouse Models for Translational Research (R01) NCI $450,000 over 3 years The purpose of this FOA is to invite applications for projects to expand and improve the utility of mouse cancer and tumor models for translational research.
June 29, 2015 New: Research Answers to NCI's Provocative Questions (R21) NCI R21: $275,000 over 2 years  These FOAs are designed to support research projects designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention.
June 29, 2015 New: Research Answers to NCI's Provocative Questions (R01) NCI R01: Budgets not limited; Project period up to 5 years  These FOAs are designed to support research projects designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions initiative. These problems and paradoxes phrased as questions are not intended to represent the full range of NCI's priorities in cancer research. Rather, they are meant to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention.